Tenax Therapeutics, Inc., a specialty pharmaceutical company, engages in identifying, developing, and commercializing products for cardiovascular and pulmonary diseases in the United States and Canada. It develops TNX-103 and TNX-102 (levosimendan) that have completed phase II clinical trials for the treatment of patients with pulmonary hypertension associated with heart failure with preserved ejection fraction and associated pulmonary hypertension; and TNX-201 (imatinib), a tyrosine kinase inhibitor for the treatment of pulmonary arterial …
Over the last 12 months, insiders at Tenax Therapeutics, Inc. have bought $12,498 and sold $0 worth of Tenax Therapeutics, Inc. stock.
On average, over the past 5 years, insiders at Tenax Therapeutics, Inc. have bought $373,101 and sold $0 worth of stock each year.
Highest buying activity among insiders over the last 12 months: Davidson Michael H. (director) — $15,000. PROEHL GERALD T (director) — $14,994.
The last purchase of 2,500 shares for transaction amount of $7,500 was made by Davidson Michael H. (director) on 2024‑08‑08.
2024-08-08 | director | 2,500 0.1209% | $3.00 | $7,500 | -3.38% | |||
2024-08-08 | director | 1,666 0.0806% | $3.00 | $4,998 | -3.38% | |||
2020-09-08 | 8,543 0.0707% | $1.46 | $12,473 | +29.93% | ||||
2020-09-04 | 23,457 0.181% | $1.41 | $33,074 | +25.85% | ||||
2020-09-03 | 36,000 0.2897% | $1.39 | $50,040 | +32.73% | ||||
2020-09-02 | 20,000 0.1666% | $1.47 | $29,400 | +29.93% | ||||
2020-09-01 | 30,000 0.2448% | $1.46 | $43,800 | +28.13% | ||||
2020-08-31 | 20,000 0.1632% | $1.45 | $29,000 | +29.02% | ||||
2020-08-27 | 12,000 0.0966% | $1.50 | $18,000 | +23.00% | ||||
2020-08-26 | 10 percent owner | 12,000 0.0959% | $1.50 | $18,000 | +22.19% | |||
2020-08-25 | 10 percent owner | 17,211 0.1341% | $1.53 | $26,333 | +16.77% | |||
2020-08-24 | 10 percent owner | 5,692 0.0468% | $1.47 | $8,367 | +28.13% | |||
2020-08-21 | 116,242 0.8861% | $1.44 | $167,388 | +21.71% | ||||
2020-08-20 | 124,472 1.0016% | $1.53 | $190,442 | +20.59% | ||||
2020-08-19 | 70,767 0.5617% | $1.45 | $102,612 | +25.51% | ||||
2020-05-18 | director | 5,000 0.0501% | $0.95 | $4,774 | +41.18% | |||
2017-12-18 | director | 12,950 0.0467% | $0.45 | $5,887 | -30.43% | |||
2017-11-14 | Sale | director | 12,950 0.0461% | $0.39 | $5,051 | -18.43% | ||
2016-11-23 | director | 14,449 0.0026% | $1.76 | $25,430 | -70.29% | |||
2016-11-22 | director | 15,433 0.0026% | $1.59 | $24,538 | -69.05% |